In today’s briefing:
- Mynt (GCash) IPO: Analysis of Deal Terms and Valuation
- Aequitas: Pateo IPO Lockup – Shares Under Pressure as >US$870m of Pre-IPO Shares to Be Unlocked
- IPO Databook: Onyx International (HK) – Sep 2026
- ADARx Pharmaceuticals (ADRX): Bio IPO Opens 30% Higher, but Selling Pressure Builds Into the Close
- IPO Databook: The Wella Company (WELA US) – Sep 2026
Mynt (GCash) IPO: Analysis of Deal Terms and Valuation
- Mynt, the digital payments and consumer finance platform behind GCash, launched its PSE IPO to raise up to USD 1,279m. MS, JPM, and UBS are the joint global coordinators.
- In this note, we look at the deal terms and provide our thoughts on valuation for the company.
- We look at the quality of the cornerstone investors and assess the risk-reward of the deal.
Aequitas: Pateo IPO Lockup – Shares Under Pressure as >US$870m of Pre-IPO Shares to Be Unlocked
- Pateo Connect Technology (PTC HK) raised US$140m from its Hong Kong IPO in September 2025 via a primary offering of HKD102.23/share in its IPO.
- It is one of the largest domestic providers of smart cockpit and intelligent connectivity solutions in China, providing full-stack smart cockpit solution and cloud-based vehicle connectivity, for Chinese OEMs.
- In this note, we will talk about the lockup dynamics and possible placement.
IPO Databook: Onyx International (HK) – Sep 2026
- Onyx International Inc. is a global consumer technology electronics brand in the knowledge-driven productivity tools industry, offering e-paper tablets and e-notes powered by its BOOX OS.
- Onyx International Inc. was the largest knowledge-driven productivity tool brand in China and the second largest globally in 2025 with 4.2% market share.
- Revenue increased from RMB803,580 thousand in 2023 to RMB1,128,185 thousand in 2025. However, profit for the period decreased in H1 2026, and the gearing ratio increased significantly.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.
ADARx Pharmaceuticals (ADRX): Bio IPO Opens 30% Higher, but Selling Pressure Builds Into the Close
- ADARx upsized its IPO to 26.3 million shares at $17.00, the high end of the range, opening at $22.10 for a 30% gain.
- The offering was 10 times oversubscribed, with the top 25 accounts receiving 95% of shares and nearly 100 accounts receiving zero allocation.
- Shares closed at $19.35 after reaching $23.21, highlighting persistent selling pressure despite strong demand and a constructive biotech IPO outcome.
IPO Databook: The Wella Company (WELA US) – Sep 2026
- The Wella Company is the world’s largest pure-play hair and nail company, operating in over 100 countries and generating $2.9 billion in net revenue in fiscal 2026.
- Wella Professionals held the #1 global brand rank in salon hair color for six consecutive years, and OPI holds the #1 global rank in premium retail nail brands.
- The company reported net income of $62,305 thousand for FY2026, but had net losses in four of the most recent five fiscal years.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

